CardioPharmaGENET Featured in the European Heart Journal

We are pleased to announce the publication of a new article introducing CardioPharmaGENET in the prestigious European Heart Journal, published on behalf of the European Society of Cardiology (ESC). The CardioPulse article “CardioPharmaGENET: A New European Network for Pharmacogenomics-Driven Cardiovascular Care,” authored by Adna Ašić, Svetlana Frolova, and Yvan Devaux, was published in October 2026, just before the end of Grant Period 1 of the Action.

The publication introduces the Action’s vision, scientific objectives, and five Working Groups, highlighting the importance of coordinated European efforts to accelerate the integration of pharmacogenomics into cardiovascular care. It also presents opportunities for international collaboration, interdisciplinary research, and the active involvement of Young Researchers and Innovators (YRIs). With over 300 members representing 43 countries, CardioPharmaGENET continues to build a multidisciplinary network dedicated to advancing safer, more effective, and personalized cardiovascular treatments.

Read the article: https://doi.org/10.1093/eurheartj/ehag772

Join CardioPharmaGENET: https://www.cost.eu/actions/CA24165/